Despite having spent nearly $8 million on federal lobbying since 2005, home health products maker Invacare (NYSE:IVC) doesn’t have much to show for its efforts.Invacare has plenty of reasons to lobby Congress, because federal policy has a greater impact on the Elyria, Ohio-based firm than most. Medicare reimbursement rates determine the price that Invacare’s equipment-dealer [...]
[Read more of this report]
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Dr. John D. HalamkaChief Medical Information Officer’s role becoming more important
Amy SiegelHow low can you go? Creating value with cheap medical devices
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Lisa Suennen2012 JP Morgan Healthcare’s (wo)men’s club is changing in a good way
Joe HageA huge American opportunity waiting to happen
Doug MowenMed tech consolidation brings a need for focus. Here are 2 ways to get it
